abstract |
A respiratory condition selected from cough, acute / chronic bronchitis, chronic obstructive pulmonary disease (COPD), cystic fibrosis and other respiratory inflammatory diseases caused by damaged respiratory cells in a patient. Providing a method for restoring the activity for cell proliferation of damaged respiratory cells in a patient after viral or bacterial infection in the manufacture of a therapeutic agent. N-acetyl-D-mannosamine, N-acetylneuraminic acid, CMP capable of accelerating recovery of viability of damaged cells by repairing sialyl glycoconjugates on airway cells -Use of sialic acid. [Selection figure] None |